LAP (Leucine Aminopeptidase) Test
🧬 LAP (Leucine Aminopeptidase) Test: Complete Clinical Guide
Sensitive marker for cholestasis and hepatobiliary disease
Leucine Aminopeptidase (LAP) is a membrane-bound enzyme primarily found in the liver, bile ducts, pancreas, and placenta. It plays a role in cleaving N-terminal leucine from peptide chains.
Clinically, LAP rises early and sensitively in conditions involving bile duct obstruction and cholestasis, making it valuable for the evaluation of hepatobiliary disorders.
This article provides a structured, evidence-based explanation suitable for medical professionals, laboratorians, and students.
1. 🧪 What Is LAP?
LAP is a zinc-dependent metalloprotease (molecular weight ~250 kDa) located on:
- Hepatocyte membranes
- Bile canalicular epithelium
- Pancreatic tissue
- Placenta (leading to physiologic rise during pregnancy)
When the biliary system is obstructed or inflamed, cell membrane enzymes are released into the bloodstream, causing a marked increase in LAP.
💡 When interpreted together with ALP and γ-GTP, LAP improves diagnostic accuracy for cholestatic disorders.
2. 🎯 Clinical Indications for LAP Testing
✔ 1) Detection of Extrahepatic Bile Duct Obstruction
Highly useful in:
- Choledocholithiasis (common bile duct stones)
- Cholangitis
- Tumor-induced biliary obstruction
- Strictures of the bile ducts
ALP and GGT usually rise in parallel.
✔ 2) Evaluation of Hepatobiliary Diseases
LAP helps assess:
- Obstructive jaundice
- Primary biliary cholangitis (PBC)
- Primary sclerosing cholangitis (PSC)
- Intrahepatic cholestasis
✔ 3) Differentiating Hepatocellular vs. Cholestatic Injury
- Hepatocellular pattern: Marked AST/ALT rise with mild LAP elevation
- Cholestatic pattern: LAP, ALP, GGT all elevated
✔ 4) Malignant Conditions
LAP may rise in:
- Cholangiocarcinoma
- Pancreatic head cancer with biliary compression
- Hepatocellular carcinoma
- Metastatic tumors invading bile ducts
3. 🔬 Test Method: Colorimetric Assay
Most laboratories measure LAP using colorimetry, based on substrate cleavage and subsequent color formation.
✔ Principle
LAP catalyzes the hydrolysis of substrates such as L-leucyl-β-naphthylamide, producing:
- β-naphthylamine, which reacts with diazo compounds
- A red or violet color develops
- Color intensity at 520–540 nm ∝ LAP activity
✔ Advantages
- Simple, rapid, and compatible with automation
- Highly sensitive to cholestatic disorders
- Helpful when ALP or GGT results are ambiguous
4. 📊 Reference Ranges
| Category | Reference Range |
|---|---|
| Adults | 30–70 IU/L (method-dependent) |
| Pregnancy (2nd–3rd trimester) | Physiological elevation |
| Children | Slightly higher than adults |
Values vary slightly depending on reagent and analyzer.
5. 🩺 Clinical Significance of Increased or Decreased LAP
🔺 When LAP Is Elevated (Clinically Important)
1) Bile Duct Obstruction (Most Common & Significant)
- CBD stones
- Cholangitis
- Pancreatic head tumor compressing the duct
- Biliary strictures
LAP often rises earlier than ALT/AST.
2) Intrahepatic or Extrahepatic Cholestasis
Conditions include:
- Drug-induced liver injury (cholestatic type)
- PBC / PSC
- Acute hepatitis with cholestatic features
3) Liver Diseases
- Cirrhosis
- Steatohepatitis (NASH)
- Acute liver injury
4) Pancreatic Disorders
- Pancreatic cancer
- Pancreatitis with secondary bile duct compression
5) Pregnancy
LAP rises physiologically due to placental LAP.
However, rapid or excessive elevation may warrant evaluation for:
- HELLP syndrome
- Severe preeclampsia
6) Malignancies
- Hepatocellular carcinoma
- Cholangiocarcinoma
- Metastatic tumors infiltrating the biliary system
🔻 LAP Decrease (Rare)
Observed in:
- Severe liver failure (enzyme production failure)
- Zinc deficiency (due to zinc-dependent nature of LAP)
- Extremely rare inherited aminopeptidase deficiencies
Clinical significance is limited.
6. 🩻 Important Pitfalls When Interpreting LAP
⚠ 1) ALP vs LAP Elevation
- ALP ↑, LAP normal → consider bone disorders (osteoporosis, Paget’s disease)
- ALP ↑, LAP ↑ → suggests cholestasis / biliary obstruction
⚠ 2) Physiologic Rise During Pregnancy
Not pathological unless accompanied by:
- Symptoms
- Hypertension
- Elevated AST/ALT or low platelets
⚠ 3) Early Marker of Cholestasis
LAP can increase before clinical jaundice or bilirubin elevation, helping early detection.
⚠ 4) Drug-Induced Cholestasis
Medications such as:
- Lithium
- Certain antibiotics
- Antiepileptic drugs
may elevate LAP.
⚠ 5) Late-Stage Liver Disease
Severe cirrhosis may show normal or low LAP due to impaired enzyme synthesis.
7. 📚 References
- Tietz NW. Fundamentals of Clinical Chemistry.
- Burtis CA, Bruns DE. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics.
- Henry JB. Clinical Diagnosis and Management by Laboratory Methods.
- Sherlock’s Diseases of the Liver and Biliary System.
- AACC (American Association for Clinical Chemistry) Guidelines on Aminopeptidase Testing.
- Gastroenterology & Hepatology Reviews: Enzyme Markers of Cholestasis.